Cargando...

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy

Background and objective The rate of end-stage renal disease from lupus nephritis has not declined, in spite of recent advances in therapeutics, such as mycophenolate mofetil (MMF). To provide insight into rates of the clinical outcomes in current practice after biopsy-proven lupus nephritis, we use...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cureus
Main Authors: Timlin, Homa, Magder, Laurence, Petri, Michelle
Formato: Artigo
Idioma:Inglês
Publicado: Cureus 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796813/
https://ncbi.nlm.nih.gov/pubmed/29410944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1907
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!